Interleukin-2 signaling and inherited immunodeficiency

American Journal of Human Genetics

Volumn 65, Issue 2, 1999, Pages 287-293

  Cacalano, Nicholas A ^a   Johnston, James A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 9; RECEPTOR SUBUNIT;

COMBINED IMMUNODEFICIENCY; CYTOKINE RELEASE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOGENETICS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; X CHROMOSOME LINKAGE;

EID: 0033358554     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302518     Document Type: Article

References (30)

1. Bazan JF (1990) Haemopoietic receptors and helical cytokines. Immunol Today 11:350-354
2. Buckley RH, Schiff RI, Schiff SE, Markert ML, Williams LW, Harville TO, Roberts JL, et al (1997) Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 130: 378-387
3. Cacalano NA, Migone TS, Bazan F, Hanson EP, Chen M, Candotti F, O'Shea JJ, et al (1999) Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain. EMBO J 18:1549-1558
4. Candotti F, Oakes SA, Johnston JA, Giliani S, Schumacher RF, Mella P, Fiorini M, et al (1997) Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood 90:3996-4003
5. Candotti F, O'Shea JJ, Villa A (1998) Severe combined immune deficiencies due to defects of the common γ chain-Jak3 signaling pathway. Springer Semin Immunopathol 19:401-415
6. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K (1997) Specific inhibition of STAT3 signal transduction by PTAS3. Science 278:1803-1805
7. DiSanto JP, Rieux-Laucat F, Dautry-Varsat A, Fischer A, de Saint Basile G (1994) Defective human interleukin 2 receptor γ chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells. Proc Natl Acad Sci USA 91:9466-9470
8. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, et al (1997) A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924
9. Friedmann MC, Migone TS, Russell SM, Leonard WJ (1996) Different interleukin 2 receptor β-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc Natl Acad Sci USA 93:2077-2082
10. Girault JA, Labesse G, Mornon JP, Callebaut I (1999) The N-termini of FAK and JAKs contain divergent band 4.1 domains. Trends Biochem Sci 24:54-57
11. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA (1997) The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. N Engl J Med 337:1720-1725
12. Hoey T, Grusby MJ (1999) STATs as mediators of cytokine-induced responses. Adv Immunol 71:145-162
13. Ihle JN, Kerr IM (1995) Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 11:69-74
14. Kumaki S, Ochs HD, Kuropatwinski KK, Kunno T, Timour MS, Cosman D, Baumann H (1999) A novel mutant gammac chain from a patient with a typical X-linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL-2 and IL-4 receptor action. Clin Exp Immunol 115:356-361
15. Macchi P, Villa A, Gillani S, Sacco MG, Frattini A, Porta F, Ugazio AG, et al (1995) Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65-68
16. Migone TS, Cacalano NA, Taylor N, Yi T, Waldmann TA, Johnston JA (1998) Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor: loss of SHP-1 expression in human T-lymphotropic virus type 1-transformed T cells. Proc Natl Acad Sci USA 95: 3845-3850
17. Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ (1993) Interleukin-2 receptor γ chain: a functional component of the interleukin-7 receptor. Science 262:1877-1880
18. O'Shea JJ (1997) Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 7:1-11
19. Puck JM (1996) IL-2RGbase: a database of γc-chain defects causing human X-SCID. Immunol Today 17:507-511
20. Puel A, Ziegler SF, Buckley RH, Leonard WJ (1998) Defective II.7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 20:394-397
21. Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Friedmann M, Berg M, et al (1994) Interaction of IL-2R β and γc chains with Jak1 and Jak 3: implications for XSCID and XCID. Science 266:1042-1045
22. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone TS, et al (1995) Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797-800
23. Schindler C, Darnell JE (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64:621-651
24. Sharfe N, Shahar M, Roifman CM (1997) An interleukin-2 receptor γ chain mutation with normal thymus morphology. J Clin Invest 100:3036-3043
25. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921
26. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, et al (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841-850
27. Uribe L, Weinberg KI (1998) X-linked SCID and other defects of cytokine pathways. Semin Hematol 35:299-309
28. von Freeden-Jeffry U, Solvason N, Howard M, Murray R (1997) The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7:147-154
29. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R (1995) Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 181:1519-1526
30. Zhu MH, John S, Berg M, Leonard WJ (1999) Functional association of Nmi with Stat5 and Stat1 in IL-2-and IFNγ-mediated signaling. Cell 96:121-130